290 related articles for article (PubMed ID: 803916)
21. Quantitative studies of the growth and rejection of allogeneic tumour cells in mouse cerebrospinal fluid. Elimination in the absence of H-2 differences.
Doherty PC; Zinkernagel RM
Clin Exp Immunol; 1975 Feb; 19(2):355-66. PubMed ID: 813923
[TBL] [Abstract][Full Text] [Related]
22. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
Germain RN; Williams RM; Benacerraf B
Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
[TBL] [Abstract][Full Text] [Related]
23. Studies on T cell clonal expansion. I. Suppression of killer T cell production in vivo.
Kamat R; Henney CS
J Immunol; 1975 Dec; 115(6):1592-8. PubMed ID: 810513
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. I. Phagocytic and non-phagocytic effector cell activity against erythrocyte and tumour target cells in a 51Cr release cytotoxicity assay and [125I]IUdR growth inhibition assay.
Greenberg AH; Shen L; Medley G
Immunology; 1975 Oct; 29(4):719-29. PubMed ID: 810417
[TBL] [Abstract][Full Text] [Related]
25. Increased primary cell-mediated immunity in culture subsequent to adriamycin or daunorubicin treatment of spleen donor mice.
Orsini F; Pavelic Z; Mihich E
Cancer Res; 1977 Jun; 37(6):1719-26. PubMed ID: 66985
[TBL] [Abstract][Full Text] [Related]
26. Reaginic antibody formation in the mouse. VII. Induction of suppressor T cells for IgE and IgG antibody responses.
Takatsu K; Ishizaka K
J Immunol; 1976 May; 116(5):1257-64. PubMed ID: 1083868
[TBL] [Abstract][Full Text] [Related]
27. Specificity of rat xenogeneic cell-mediated cytolysis for the products of the K and D loci of the mouse H-2 complex.
Burakoff SJ; Dorf ME; Benacerraf B
J Immunol; 1977 May; 118(5):1795-8. PubMed ID: 67147
[TBL] [Abstract][Full Text] [Related]
28. Studies on T cell clonal expansion. II. The in vitro differentiation of pre-killer and memory T cells.
Kamat R; Henney CS
J Immunol; 1976 May; 116(5):1490-5. PubMed ID: 178799
[TBL] [Abstract][Full Text] [Related]
29. Progressive growth of immunogenic tumors: relationship between susceptibility of ascites P815 tumor cells to T-cell-mediated lysis and immune destruction in vivo.
Fahey JR; Hines DL
Cancer Res; 1987 Sep; 47(18):4759-65. PubMed ID: 3113723
[TBL] [Abstract][Full Text] [Related]
30. Augmentation of antitumor immune response by trinitrophenyl (TNP)-reactive helper T-cells: enhanced induction of tumor-specific Lyt-1+2- T-cell-mediated delayed-type hypersensitivity from spleen cells of tumor-bearing mice by TNP helpers.
Suda T; Fujiwara H; Mizushima Y; Shearer GM; Hamaoka T
J Natl Cancer Inst; 1986 Dec; 77(6):1267-72. PubMed ID: 2948049
[TBL] [Abstract][Full Text] [Related]
31. Effect of tumor cells on the generation of cytotoxic T lymphocytes in vitro. I. Accessory cell functions of mouse tumor cells in the generation of cytotoxic T lymphocytes in vitro: replacement of adherent phagocytic cells by tumor cells or 2-mercaptoethanol.
Koren HS; Hodes RJ
Eur J Immunol; 1977 Jun; 7(6):394-400. PubMed ID: 302208
[TBL] [Abstract][Full Text] [Related]
32. The induction of hapten-specific immunologic tolerance and immunity in B lymphocytes. I. The effect of delayed immunization on the adoptive response to TNP-LPS.
Fidler JM
J Immunol; 1976 Apr; 116(4):1188-93. PubMed ID: 943442
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of specific and non-specific tumour immunity after azathioprine treatment of mice.
Purves EC
Clin Exp Immunol; 1975 Nov; 22(2):348-58. PubMed ID: 813934
[TBL] [Abstract][Full Text] [Related]
34. In vitro induction of polyclonal killer T cells with 2-mercaptoethanol and the essential role of macrophages in this process.
Igarashi T; Okada M; Kishimoto T; Yamamura Y
J Immunol; 1977 May; 118(5):1697-703. PubMed ID: 67145
[TBL] [Abstract][Full Text] [Related]
35. Potentiation of cytotoxic T-cell function by virus.
Reinisch CL; Schlossman SF
J Natl Cancer Inst; 1976 Dec; 57(6):1277-81. PubMed ID: 63565
[TBL] [Abstract][Full Text] [Related]
36. The potentiality of antibody-producing cells. I Bispecific cell occurrence in double stimulated cultures of syngeneic or allogeneic spleen cells of the mouse.
Couderc J; Bleux C; Birrien JL; Liacopoulos P
Immunology; 1975 Oct; 29(4):653-64. PubMed ID: 1102444
[TBL] [Abstract][Full Text] [Related]
37. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2.
Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W
J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360
[TBL] [Abstract][Full Text] [Related]
38. The effect of organophosphorus inhibitors, p-nitrophenol and cytochalasin B on cytotoxic killing of tumour cells by immune spleen cells, and the effect of shaking.
Ferluga J; Asherson GL; Becker EL
Immunology; 1972 Oct; 23(4):577-90. PubMed ID: 4628464
[TBL] [Abstract][Full Text] [Related]
39. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells.
Williams RM; Germain RN; Benacerraf B
J Natl Cancer Inst; 1975 Mar; 54(3):697-708. PubMed ID: 1091740
[TBL] [Abstract][Full Text] [Related]
40. Lymphoid cell dependence of eosinophil response to antigen. VI. The effect of selective removal of T or B lymphocytes on the capacity of primed spleen cells to adoptively transferred immunity to tetanus toxoid.
Ponzio NM; Speirs RS
Immunology; 1975 Feb; 28(2):243-51. PubMed ID: 1079015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
